Xeris Pharmaceuticals Inc (XERS) support and resistance · rev $175.2M
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
This page maps Xeris Pharmaceuticals Inc (XERS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
XERS currently screens at market cap $760.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new XERS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the XERS quote page for the session range and the stock page for the full model.
Not investment advice.